top of page
gradientForSurfBreak.png

Item List

May 3, 2022
PR Newswire
Strados Labs Receives FDA 510(k) Clearance for Home Use of its Smart Sensor Platform

Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and proprietary algorithms to provide early detection and predictions of worsening respiratory diseases, today announced it has received FDA Class II 510(k) clearance for home use of its first product, RESP®, which make this its second FDA clearance in less than 18 months.

Recent Posts

Portfolio Company

Carlsmed.png

Robotic Dog, Audio Lollipops and More Favorites From CES 2026 ...

Today Show

Jan 12, 2026

Portfolio Company

Carlsmed.png

CARL Launches Aprevo Cervical Platform for Personalized Spine Surgery ...

Yahoo Finance

Dec 9, 2025

Portfolio Company

Carlsmed.png

Jannine Versi, Co-Founder & CEO of Elektra Health ...

Fitt/Insider

Dec 9, 2025

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page